370 related articles for article (PubMed ID: 17664422)
21. Chemokine receptor CXCR2 is transactivated by p53 and induces p38-mediated cellular senescence in response to DNA damage.
Guo H; Liu Z; Xu B; Hu H; Wei Z; Liu Q; Zhang X; Ding X; Wang Y; Zhao M; Gong Y; Shao C
Aging Cell; 2013 Dec; 12(6):1110-21. PubMed ID: 23869868
[TBL] [Abstract][Full Text] [Related]
22. Lymphomas that recur after MYC suppression continue to exhibit oncogene addiction.
Choi PS; van Riggelen J; Gentles AJ; Bachireddy P; Rakhra K; Adam SJ; Plevritis SK; Felsher DW
Proc Natl Acad Sci U S A; 2011 Oct; 108(42):17432-7. PubMed ID: 21969595
[TBL] [Abstract][Full Text] [Related]
23. MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer.
Shachaf CM; Kopelman AM; Arvanitis C; Karlsson A; Beer S; Mandl S; Bachmann MH; Borowsky AD; Ruebner B; Cardiff RD; Yang Q; Bishop JM; Contag CH; Felsher DW
Nature; 2004 Oct; 431(7012):1112-7. PubMed ID: 15475948
[TBL] [Abstract][Full Text] [Related]
24. Molecular control of the cell cycle in cancer: biological and clinical aspects.
Møller MB
Dan Med Bull; 2003 May; 50(2):118-38. PubMed ID: 12812137
[TBL] [Abstract][Full Text] [Related]
25. The c-Myc oncogene directly induces the H19 noncoding RNA by allele-specific binding to potentiate tumorigenesis.
Barsyte-Lovejoy D; Lau SK; Boutros PC; Khosravi F; Jurisica I; Andrulis IL; Tsao MS; Penn LZ
Cancer Res; 2006 May; 66(10):5330-7. PubMed ID: 16707459
[TBL] [Abstract][Full Text] [Related]
26. Rehabilitation of cancer through oncogene inactivation.
Shachaf CM; Felsher DW
Trends Mol Med; 2005 Jul; 11(7):316-21. PubMed ID: 15955741
[TBL] [Abstract][Full Text] [Related]
27. Phenobarbital causes apoptosis in conditionally immortalized mouse hepatocytes depending on deregulated c-myc expression: characterization of an unexpected effect.
Osanai M; Ogawa K; Lee GH
Cancer Res; 1997 Jul; 57(14):2896-903. PubMed ID: 9230198
[TBL] [Abstract][Full Text] [Related]
28. Depletion of ERK2 but not ERK1 abrogates oncogenic Ras-induced senescence.
Shin J; Yang J; Lee JC; Baek KH
Cell Signal; 2013 Dec; 25(12):2540-7. PubMed ID: 23993963
[TBL] [Abstract][Full Text] [Related]
29. mTOR inactivation by ROS-JNK-p53 pathway plays an essential role in psedolaric acid B induced autophagy-dependent senescence in murine fibrosarcoma L929 cells.
Qi M; Zhou H; Fan S; Li Z; Yao G; Tashiro S; Onodera S; Xia M; Ikejima T
Eur J Pharmacol; 2013 Sep; 715(1-3):76-88. PubMed ID: 23810968
[TBL] [Abstract][Full Text] [Related]
30. Genomically complex lymphomas undergo sustained tumor regression upon MYC inactivation unless they acquire novel chromosomal translocations.
Karlsson A; Giuriato S; Tang F; Fung-Weier J; Levan G; Felsher DW
Blood; 2003 Apr; 101(7):2797-803. PubMed ID: 12517816
[TBL] [Abstract][Full Text] [Related]
31. Methods to Study Myc-Regulated Cellular Senescence: An Update.
Zhang F; Bazzar W; Alzrigat M; Larsson LG
Methods Mol Biol; 2021; 2318():241-254. PubMed ID: 34019294
[TBL] [Abstract][Full Text] [Related]
32. Inactivation of MYC reverses tumorigenesis.
Li Y; Casey SC; Felsher DW
J Intern Med; 2014 Jul; 276(1):52-60. PubMed ID: 24645771
[TBL] [Abstract][Full Text] [Related]
33. ARF: connecting senescence and innate immunity for clearance.
Kearney AY; Anchang B; Plevritis S; Felsher DW
Aging (Albany NY); 2015 Sep; 7(9):613-5. PubMed ID: 26412380
[TBL] [Abstract][Full Text] [Related]
34. Myc and a Cdk2 senescence switch.
van Riggelen J; Felsher DW
Nat Cell Biol; 2010 Jan; 12(1):7-9. PubMed ID: 20027199
[TBL] [Abstract][Full Text] [Related]
35. In vivo imaging-based mathematical modeling techniques that enhance the understanding of oncogene addiction in relation to tumor growth.
Nwabugwu C; Rakhra K; Felsher D; Paik D
Comput Math Methods Med; 2013; 2013():802512. PubMed ID: 23573174
[TBL] [Abstract][Full Text] [Related]
36. The MYC oncogene as a cancer drug target.
Hermeking H
Curr Cancer Drug Targets; 2003 Jun; 3(3):163-75. PubMed ID: 12769686
[TBL] [Abstract][Full Text] [Related]
37. Oncogene withdrawal engages the immune system to induce sustained cancer regression.
Casey SC; Li Y; Fan AC; Felsher DW
J Immunother Cancer; 2014; 2():24. PubMed ID: 25089198
[TBL] [Abstract][Full Text] [Related]
38. An essential role for the immune system in the mechanism of tumor regression following targeted oncogene inactivation.
Casey SC; Li Y; Felsher DW
Immunol Res; 2014 May; 58(2-3):282-91. PubMed ID: 24791942
[TBL] [Abstract][Full Text] [Related]
39. Noncanonical roles of the immune system in eliciting oncogene addiction.
Casey SC; Bellovin DI; Felsher DW
Curr Opin Immunol; 2013 Apr; 25(2):246-58. PubMed ID: 23571026
[TBL] [Abstract][Full Text] [Related]
40. Myc Supports Self-Renewal of Basal Cells in the Esophageal Epithelium.
Hishida T; Vazquez-Ferrer E; Hishida-Nozaki Y; Takemoto Y; Hatanaka F; Yoshida K; Prieto J; Sahu SK; Takahashi Y; Reddy P; O'Keefe DD; Rodriguez Esteban C; Knoepfler PS; Nuñez Delicado E; Castells A; Campistol JM; Kato R; Nakagawa H; Izpisua Belmonte JC
Front Cell Dev Biol; 2022; 10():786031. PubMed ID: 35309931
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
